Cabico, Fel Ezekiel E.
HRN: 22-71-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/17/2023
03/23/2023
IVTT
16mg
Q36h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes